Rx payments in Utah

Drug companies made up to $25.8 million in payments to Utah doctors and health professionals to promote their drugs between 2009 and 2012, according to a ProPublica "Dollars for Docs" repository, the largest of its kind. And that's just the beginning. Many drugmakers have yet to fully disclose payments.
A growing market
Drug company payments to Utah have grown sixfold in four years.
$12.9 million
$12 million

Where the money went

Research efforts received most of the money (2009-12).

Single largest research payments

Drugmaker Cephalon Merck Merck Pzer Pzer Pzer Pzer Pzer Pzer Pzer Pzer Pzer Payment
$1.7 million $857,000 $611,211 $581,309 $486,220 $423,761 $396,938 $303,732 $301,099 $286,420 $280,489 $259,489

Recipient
Lynn Webster, anesthesiologist/medical director, CRI LifeTree Research Miroslav Backonja, neurologist/ medical director, CRI LifeTree Research Lynn Webster, anesthesiologist/medical director, CRI LifeTree Research Mark Alan Turner, urgent-care specialist, Advanced Clinical Research University of Utah Shane Glade Christensen, family medicine/investigator, J Lewis Research Inc Corey Ericksen, Ericksen Research and Development Patrick R. Brain, Jean Brown Associates, Inc David Bruce Jack, bariatrician, Lone Peak Family Medicine University of Utah Shane Glad Christensen, family medicine/investigator, J Lewis Research Inc Derek David Muse, family doctor, Jean Brown Associates Inc

Research

$17.5 million

Lectures

$5.9 million

9
$6.6 million

6
$4.3 million

Single largest payments for speaking (lectures)

GlaxoSmithKline GlaxoSmithKline Eli Lilly
$88,100 $85,350 $74,550
Eliot Brinton, internist, University of Utah Lipid Clinic Eliot Brinton, internist, University of Utah Lipid Clinic Michael O. Measom, psychiatrist, Valley Mental Health

3 $2 million

Travel

$526,890
Consulting, meals, other

Single largest payments for consulting

Pzer Eli Lilly Eli Lilly
$23,264 $22,706 $21,500
Kristina Patrice Callis-Dufn, dermatologist, University Hospital Clinic Cynthia White Noel G. Gardner, psychiatrist

09 10

11 12

$2 million

About the data ProPublica's "Dollars for Doc" database is a collection of drug company payment disclosures from 2009 to 2012. Data span 15 manufacturers comprising 47 percent of the U.S. pharmaceutical market. Some drugmakers have yet to report payments; others have made only partial disclosures. There is no standardization in reporting, and individuals are sometimes linked with large research grants they took no part in. The Salt Lake Tribune Source: ProPublica